Literature DB >> 4787984

Antibody response to inactivated influenza vaccine given by different routes in patients with chronic bronchopulmonary disease.

S L Shore, C W Potter, C H Stuart-Harris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4787984      PMCID: PMC470107          DOI: 10.1136/thx.28.6.721

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  15 in total

Review 1.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

Review 2.  Control of influenza: lack of knowledge versus lack of application of knowledge.

Authors:  C H Stuart-Harris
Journal:  Arch Environ Health       Date:  1970-09

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man.

Authors:  S R Mostow; S C Schoenbaum; W R Dowdle; M T Coleman; H S Kaye; J C Hierholzer
Journal:  Am J Epidemiol       Date:  1970-10       Impact factor: 4.897

5.  Isolation of crystalline lactoferrin from human milk.

Authors:  B G Johansson
Journal:  Acta Chem Scand       Date:  1969

6.  The role of immunoglobulin A in endogenous bronchial defense mechanisms in chronic bronchitis.

Authors:  T C Medici; H Buergi
Journal:  Am Rev Respir Dis       Date:  1971-06

7.  Comparative evaluation of commercial precipitating antisera against human IgM and IgM.

Authors:  C B Reimer; D J Phillips; S E Maddison; S L Shore
Journal:  J Lab Clin Med       Date:  1970-12

8.  Comparative evaluation of commercial precipitating antisera against human IgA.

Authors:  D J Phillips; S L Shore; S E Maddison; D S Gordon; C B Reimer
Journal:  J Lab Clin Med       Date:  1971-04

9.  Quantitative hemadsorption, a new assay technique. II. Assay of neutralizing antibodies to hemadsorbing viruses.

Authors:  N B Finter
Journal:  J Immunol       Date:  1967-01       Impact factor: 5.422

10.  The production of neutralizing activity in serum and nasal secretion following immunization with influenza B virus.

Authors:  J C Downie; C H Stuart-Harris
Journal:  J Hyg (Lond)       Date:  1970-06
View more
  5 in total

1.  Aspects of serum and sputum antibody in chronic airways obstruction.

Authors:  C W Clarke
Journal:  Thorax       Date:  1976-12       Impact factor: 9.139

2.  Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

Review 3.  Chronic obstructive pulmonary disease.

Authors:  N R Anthonisen
Journal:  CMAJ       Date:  1988-03-15       Impact factor: 8.262

4.  Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

5.  Immunity following intranasal administration of an inactivated, freeze-dried A/England/42/72 vaccine.

Authors:  C W Potter; R Jennings; C McLaren; A Clarke
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.